These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26654770)

  • 1. Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.
    Malak PN; Dannenmann B; Hirth A; Rothfuss OC; Schulze-Osthoff K
    Cell Cycle; 2015; 14(23):3748-54. PubMed ID: 26654770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis.
    Dai X; Liu P; Lau AW; Liu Y; Inuzuka H
    Cancer Med; 2014 Oct; 3(5):1211-24. PubMed ID: 25116380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
    Cai Y; Dai X; Zhang Q; Dai Z
    Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3K4 Methyltransferase Set1a Is A Key Oct4 Coactivator Essential for Generation of Oct4 Positive Inner Cell Mass.
    Fang L; Zhang J; Zhang H; Yang X; Jin X; Zhang L; Skalnik DG; Jin Y; Zhang Y; Huang X; Li J; Wong J
    Stem Cells; 2016 Mar; 34(3):565-80. PubMed ID: 26785054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
    Soufi A; Zaret KS
    Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
    An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
    Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detrimental effects of diabetes on pluripotency determined by KLF4, SOX2, C-MYC and OCT4 immunoreactivity in rat testes.
    Aktug H; Uysal A; Yavasoglu A; Oltulu F; Akarca SO; Yilmaz-Dilsiz O; Oktem G
    Adv Clin Exp Med; 2013; 22(3):327-35. PubMed ID: 23828673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the Sox2, c-Myc, and Oct4 promoters.
    Chen H; Jin K; Song J; Zuo Q; Yang H; Zhang Y; Li B
    J Cell Biochem; 2019 Jan; 120(1):332-342. PubMed ID: 30277598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A suboptimal OCT4-SOX2 binding site facilitates the naïve-state specific function of a Klf4 enhancer.
    Waite JB; Boytz R; Traeger AR; Lind TM; Lumbao-Conradson K; Torigoe SE
    PLoS One; 2024; 19(9):e0311120. PubMed ID: 39348365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
    Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
    Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
    Liu L; Wu L; Wei X; Ling J
    Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth.
    Villodre ES; Felipe KB; Oyama MZ; Oliveira FH; Lopez PLDC; Solari C; Sevlever G; Guberman A; Lenz G
    Biochem Biophys Res Commun; 2019 Sep; 517(2):324-329. PubMed ID: 31353083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
    Qi H; Pei D
    Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
    [No Abstract]   [Full Text] [Related]  

  • 18. Directing reprogramming to pluripotency by transcription factors.
    Adachi K; Schöler HR
    Curr Opin Genet Dev; 2012 Oct; 22(5):416-22. PubMed ID: 22868173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells.
    Jeong CH; Cho YY; Kim MO; Kim SH; Cho EJ; Lee SY; Jeon YJ; Lee KY; Yao K; Keum YS; Bode AM; Dong Z
    Stem Cells; 2010 Dec; 28(12):2141-50. PubMed ID: 20945330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox2 expression is regulated by a negative feedback loop in embryonic stem cells that involves AKT signaling and FoxO1.
    Ormsbee Golden BD; Wuebben EL; Rizzino A
    PLoS One; 2013; 8(10):e76345. PubMed ID: 24116102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.